Ana Rita Nobre

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 6

Top Topics

Breast Cancer Cells

Signaling Pathway

Top Venues

Nature genetics

The Journal of experimental medicine

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Veronica Calvo, Wei Zheng, Anna Adam-Artigues, Kirk A Staschke, Xin Huang, Julie F Cheung, Ana Rita Nobre, Sho Fujisawa, David Liu, Maria Fumagalli, David Surguladze, Michael E Stokes, Ari Nowacek, Mark J Mulvihill, Eduardo F Farias, Julio A Aguirre-Ghiso
A PERK-Specific Inhibitor Blocks Metastatic Progression by Limiting Integrated Stress Response-Dependent Survival of Quiescent Cancer Cells. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Ana Rita Nobre, Adrienne A Boire
Skip to the end: metastasis before tumorigenesis. Nature genetics 54 (12) (2022)
Ana Rita Nobre, Adrienne A Boire
Skip to the end: metastasis before tumorigenesis. Nature genetics 54 (12) (2022)
Ana Rita Nobre, Adrienne A Boire
Skip to the end: metastasis before tumorigenesis. Nature genetics 54 (12) (2022)
Ana Rita Nobre, Erica Dalla, Jihong Yang, Xin Huang, Lena Wullkopf, Emma Risson, Pedram Razghandi, Melisa Lopez Anton, Wei Zheng, José A Seoane, Christina Curtis, Ephraim Kenigsberg, Jianlong Wang, Julio A Aguirre-Ghiso
ZFP281 drives a mesenchymal-like dormancy program in early disseminated breast cancer cells that prevents metastatic outgrowth in the lung. Nature cancer 3 (10) (2022)
Bassem D Khalil, Roberto Sanchez, Tasrina Rahman, Carolina Rodriguez-Tirado, Stefan Moritsch, Alba Rodriguez Martinez, Brett A Miles, Eduardo F Farias, Mihaly Mezei, Ana Rita Nobre, Deepak K Singh, Nupura Kale, Karl Christoph Sproll, Maria Soledad Sosa, Julio A Aguirre-Ghiso
An NR2F1-specific agonist suppresses metastasis by inducing cancer cell dormancy. The Journal of experimental medicine 219 (1) (2021)